A subcutaneous vaccination approach with CpG oligodeoxynucleotide, OX40 mAb, and tumor lysate at a remote site in a murine orthotopic HGG model was developed to induce the activation of T cells distantly, while monitoring their distribution in stimulated lymphoid organs with respect to the observed therapeutic effects. This evidence concerns the gene TNFRSF4 and neoplasm.